NCT06084338View on ClinicalTrials.gov

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

November 29, 2027

Study Completion Date

December 31, 2028

Conditions
Prostate Cancer
Interventions
RADIATION

stereotactic ablative radiotherapy

Metastasis directed

DRUG

Pluvicto

PSMA targeted radiopharmaceutical therapy

DRUG

topical testosterone

Topical testosterone 1.62% gel

Trial Locations (3)

90822

NOT_YET_RECRUITING

VA Long Beach Healthcare System, Long Beach, CA, Long Beach

90073-1003

RECRUITING

VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles

60141-3030

NOT_YET_RECRUITING

Edward Hines Jr. VA Hospital, Hines, IL, Hines

All Listed Sponsors
lead

VA Office of Research and Development

FED